Replay available

iSpecimen Inc. (ISPC) Q2 2023 Earnings Call

iSpecimen Inc. (NASDAQ: ISPC) Q2 2023 earnings conference call, held 2023-08-02. Replay captured from the company's public earnings webcast.

Wed, August 2, 2023 at 8:30 AMendedReplay
iSpecimen Inc. (ISPC) Q2 2023 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Tracy Curley

Chief Executive Officer & Chief Financial Officer

Evan Cox

Vice President & Head of Product Management

Eric Landlois

Chief Revenue Officer

Matt Hewitt

Analyst, Craig-Hallum Capital Group

Replay transcript excerpt

everyone and welcome to i specimens second quarter 2023 results conference call at this time participants are in a listen-only mode a question and answer session will follow management's remarks this conference call is being recorded a replay of today's call will be available on the investor relations section of i specimens website and will remain posted for the next 30 days i will now hand the call over to phil carson Carlson of KCSA for introductions and the reading of the Safe Harbor Statement. Please go ahead. Thank you, operator. Good morning, everyone, and welcome to iSpecimen's second quarter 2023 results conference call. With us on today's call is Tracy Curley, Chief Executive Officer and Chief Financial Officer, Benjamin Bielak, Chief Information Officer, Eric Landlois, Chief Revenue Officer, and Evan Cox, VP and Head of Product Management. Before we begin, I would like to remind you that today's call contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended and Section 21E of the Securities and Exchange Act of 1934 as amended concerning future events. Words such as may, should, projects, expects, intends, plans, believes, anticipates, hopes, estimates, and variations of such words and similar expressions are intended to identify forward-looking statements. These statements are subject to numerous conditions, many of which are beyond the control of the company, including those set forth in the risk factors section of the company's amendment number one to the annual report on Form 10-K for the year ended December 31, 2022, filed with the SEC on March 30, 2023, and the risk factors set forth in Part 2, Item 1A of our quarterly report on Form 10-Q for the quarterly period end of June 30, 2023, being f...

More from Ispecimen Inc.